MIR4447: A Drug Target / Disease Biomarker (G100616485)

MIR4447: A Drug Target / Disease Biomarker

MIR4447 is a protein that is expressed in various tissues throughout the body, including the brain, lungs, heart, and kidneys. It is a member of the MIR family of RNA-binding proteins, which are known for their ability to interact with small RNA molecules. One of the unique features of MIR4447 is its ability to form a stable complex with a specific small RNA molecule, called miR-202, which is produced by the microRNA pathway.

The miR-202 protein is a non-coding RNA molecule that is approximately 20 amino acids long. It is expressed in various tissues throughout the body and is involved in the regulation of various cellular processes, including cell growth, apoptosis, and inflammation. MIR4447 has been shown to play a critical role in the regulation of miR-202 expression by binding to its active site, which allows it to form a stable complex with the miR-202 molecule.

One of the key functions of MIR4447 is its ability to regulate the levels of miR-202 in different cell types. For example, studies have shown that MIR4447 is highly expressed in the brain and that it is involved in the regulation of miR-202 expression in this tissue. This suggests that MIR4447 may play a critical role in the development and progression of various neurological disorders, including Alzheimer's disease and other forms of dementia.

Another function of MIR4447 is its ability to regulate the activity of cellular signaling pathways. For example, studies have shown that MIR4447 is involved in the regulation of the PI3K/Akt signaling pathway, which is involved in the regulation of various cellular processes, including cell growth, apoptosis, and inflammation. This suggests that MIR4447 may play a critical role in the regulation of cellular signaling pathways and that it may be a useful target for the development of new therapeutic strategies for various diseases.

In addition to its role in the regulation of miR-202 and cellular signaling pathways, MIR4447 is also involved in the regulation of various cellular processes that are important for maintaining cellular homeostasis. For example, studies have shown that MIR4447 is involved in the regulation of cell adhesion, which is important for the maintenance of the integrity of cellular tissues and for the development of various diseases, including cancer.

MIR4447 is also involved in the regulation of cellular processes that are important for the development and maintenance of tissues and organs. For example, studies have shown that MIR4447 is involved in the regulation of cell proliferation, which is important for the development and maintenance of tissues and organs. This suggests that MIR4447 may play a critical role in the development and progression of various diseases, including cancer.

In conclusion, MIR4447 is a protein that is involved in a wide range of cellular processes that are important for maintaining cellular homeostasis and for the development and maintenance of tissues and organs. Its ability to form a stable complex with miR-202 makes it a potential drug target and a useful biomarker for the development of various diseases. Further research is needed to fully understand the role of MIR4447 in cellular processes and its potential as a drug target.

Protein Name: MicroRNA 4447

The "MIR4447 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR4447 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR4448 | MIR4449 | MIR4450 | MIR4451 | MIR4453 | MIR4453HG | MIR4454 | MIR4455 | MIR4456 | MIR4457 | MIR4458 | MIR4458HG | MIR4463 | MIR4465 | MIR4466 | MIR4467 | MIR4468 | MIR4469 | MIR4470 | MIR4472-1 | MIR4472-2 | MIR4474 | MIR4475 | MIR4476 | MIR4478 | MIR4479 | MIR448 | MIR4481 | MIR4482 | MIR4483 | MIR4484 | MIR4485 | MIR4486 | MIR4487 | MIR4488 | MIR4489 | MIR4491 | MIR4492 | MIR4493 | MIR4496 | MIR4497 | MIR4498 | MIR4499 | MIR449A | MIR449B | MIR449C | MIR4500 | MIR4500HG | MIR4501 | MIR4504 | MIR4505 | MIR4506 | MIR4507 | MIR4508 | MIR4509-1 | MIR4509-2 | MIR4509-3 | MIR450A1 | MIR450A2 | MIR450B | MIR4510 | MIR4511 | MIR4512 | MIR4513 | MIR4514 | MIR4516 | MIR4519 | MIR451A | MIR451B | MIR452 | MIR4520-1 | MIR4520-2 | MIR4521 | MIR4524A | MIR4524B | MIR4525 | MIR4526 | MIR4527 | MIR4527HG | MIR4529 | MIR4530 | MIR4531 | MIR4533 | MIR4534 | MIR4535 | MIR4536-1 | MIR4536-2 | MIR4537 | MIR4538 | MIR4539 | MIR454 | MIR4540 | MIR455 | MIR4632 | MIR4633 | MIR4634 | MIR4635 | MIR4638 | MIR4639 | MIR4640